The goal of our research is to apply genetic and genomic approaches to better understand the molecular components implicated in multiple sclerosis. The identification of genetic determinants will lead to a better understanding of the pathological mechanisms of disease, spur the generation of physiologically relevant models, and promote the development of novel therapeutics to better treat and ultimately halt disease onset and progression.